|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.24 AUD | -0.88% |
|
+7.18% | +35.35% |
| May. 08 | PolyNovo's Revenue Climbs 68.6% in April | MT |
| Mar. 04 | Polynovo Gets India OK for Listing of Dermal Scaffold Device on Government e-Portal Marketplace | MT |
PolyNovo Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported revenue was AUD 41.89 million compared to AUD 29.34 million a year ago. Net loss was AUD 1.19 million compared to AUD 4.61 million a year ago.
Basic loss per share from continuing operations was AUD 0.0018 compared to AUD 0.0069 a year ago. Diluted loss per share from continuing operations was AUD 0.0018 compared to AUD 0.0069 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.35% | 1.02B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
POLYNOVO LIMITED 
